P. Francalanci et al., A GENETIC ASSESSMENT OF TRISOMY-21 IN A PATIENT WITH PERSISTENT TRUNCUS ARTERIOSUS WHO DIED 38 YEARS AGO, The American journal of cardiology, 79(2), 1997, pp. 245
It is well known that in patients with Down syndrome there is a risk o
f 40% to 50% of associated congenital heart disease.(1) The most frequ
ent cardiac malformations are within the spectrum of either atrioventr
icular septal defect (AVSD), otherwise known as atrioventricular canal
, or ventricular septal defect (VSD).(2,3) Although the exact cause an
d mechanism of these associations are not known, it has been hypothesi
zed that, at least in some syndromes, there is a specific linkage of c
ause and effect between chromosomal anomalies, altered genetic product
, and congenital heart disease. The observation that some cardiac malf
ormations are frequent and others unusual or absent in the same syndro
mes, suggests that there may be a genetic influence on a specific phas
e and segment of cardiac morphogenesis. Thus, anomaly or absence of a
gene plays a role in the morphogenesis of certain components, but it d
oes not change the development of other cardiovascular segments. For e
xample, major conotruncal malformations, such as transposition of the
great arteries or double-outlet right ventricle are extremely rare in
trisomy 21.(3,4) In this report, we describe the case of a baby with t
he extraordinary association of persistent truncus arteriosus, interru
pted aortic arch, cleft of the mitral valve, and Down syndrome, in who
m trisomy 21 was assessed by means of molecular biology 38 years after
the patient's death.